HBK Investments’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-3,486,602
| Closed | -$162M | – | 808 |
|
|
2019
Q2 | $162M | Buy |
3,486,602
+3,446,340
| +8,560% | +$96.8M | 1.41% | 11 |
|
|
2019
Q1 | $982K | Buy |
+40,262
| New | +$838K | 0.01% | 680 |
|
|
2018
Q4 | – | Sell |
-11,700
| Closed | -$178K | – | 1515 |
|
|
2018
Q3 | $178K | Sell |
11,700
-229,406
| -95% | -$3.52M | ﹤0.01% | 1135 |
|
|
2018
Q2 | $4.05M | Sell |
241,106
-9,621
| -4% | -$153K | 0.03% | 316 |
|
|
2018
Q1 | $4.09M | Buy |
+250,727
| New | +$4.02M | 0.03% | 313 |
|
|
2017
Q3 | – | Sell |
-267,103
| Closed | -$2.24M | – | 1181 |
|
|
2017
Q2 | $2.24M | Buy |
267,103
+36,403
| +16% | +$298K | 0.01% | 389 |
|
|
2017
Q1 | $2.06M | Buy |
+230,700
| New | +$2.45M | 0.02% | 321 |
|
|
2016
Q2 | – | Sell |
-57,950
| Closed | -$171K | – | 1153 |
|
|
2016
Q1 | $171K | Sell |
57,950
-141,850
| -71% | -$425K | ﹤0.01% | 905 |
|
|
2015
Q4 | $843K | Buy |
199,800
+172,200
| +624% | +$786K | 0.01% | 617 |
|
|
2015
Q3 | $126K | Sell |
27,600
-21,453
| -44% | -$127K | ﹤0.01% | 967 |
|
|
2015
Q2 | $354K | Sell |
49,053
-95,097
| -66% | -$702K | ﹤0.01% | 799 |
|
|
2015
Q1 | $1.06M | Buy |
+144,150
| New | +$1.03M | 0.01% | 547 |
|
|
2014
Q1 | – | Sell |
-16,600
| Closed | -$83K | – | 1103 |
|
|
2013
Q4 | $83K | Buy |
+16,600
| New | +$90.4K | ﹤0.01% | 869 |
|
Other funds holding ARRY
HBK Investments's ARRY Position: Q3 2019 in Review
HBK Investments sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 3,486,602 shares — an estimated $162M sold.
HBK Investments first reported a position in ARRY in Q4 2013 and held it in 13 quarters. The position peaked at $162M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- HBK Investments reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- HBK Investments sold 3,486,602 Array Biopharma Inc shares in Q3 2019, an estimated $162M.
- HBK Investments first reported a position in Array Biopharma Inc in Q4 2013 and held it in 13 quarters.
- HBK Investments's Array Biopharma Inc position peaked at $162M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on HBK Investments's 13F filing for Q3 2019, filed 14 Nov 2019.